News AIs can be used for fracture detection, says NICE NICE has said that four artificial intelligence technologies can be deployed by the NHS to detect fractures on X-rays in urgent care.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face